NCT03869567

Brief Summary

Cerebral haemorrhages following reperfusion treatments involve not only rupture of the blood-brain barrier, but also direct damage to vessels related to the equipment used and secondary toxicity to thrombolytics. The rupture of the blood-brain barrier which results from ischemia / reperfusion is responsible for stagnation of the contrast product on the exams performed after thrombectomy. It is difficult to distinguish hyperdensities related to the stagnation of contrast product and Hemorrhage on a conventional scanner. The reference imaging is the double energy scanner performed at the thrombectomy outlet. But no study directly compared the results of the flat panel with the cone beam CT performed in immediate post-thrombectomy. The investigators propose a direct comparison of the cone beam CT with the dual energy CT performed at the exit of thrombectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 11, 2019

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

February 21, 2019

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 11, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2020

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2023

Enrollment Period

1.5 years

First QC Date

February 21, 2019

Last Update Submit

May 9, 2023

Conditions

Keywords

thrombectomyflat panel Computed tomographycone beam computed tomographyhemorrhagestrokedual energy computed tomography

Outcome Measures

Primary Outcomes (1)

  • Hemorrhage presence

    hemorrhage presence or not is determined with cone beam and scanner images

    up to two days

Secondary Outcomes (2)

  • Number of patients with hemorrhagic transformation

    24 hours from symptom onset

  • Health deterioration

    24 hours from symptom onset

Study Arms (1)

Cone beam CT

EXPERIMENTAL

A cone beam CT wll be performed just after thrombectomy on patients with acute ischemic stroke

Device: cone beam CT

Interventions

Just after thrombectomy, a cone beam CT will be done, while patient is on angiography table, in order to determine if hemorrhage image is due to contrast accumulation or blood-brain barrier disruption.

Cone beam CT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all patients with cerebral thrombectomy
  • Adults
  • Patients able to express consent
  • Signed written informed consent form
  • Covered by national health insurance

You may not qualify if:

  • minors
  • pregnancy or beast feeding
  • patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
  • obstruction to participate
  • non covered by national health insurance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens-Picardie

Amiens, 80054, France

Location

MeSH Terms

Conditions

StrokeHemorrhage

Interventions

Cone-Beam Computed Tomography

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Tomography, X-Ray ComputedTomography, X-RayRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomography

Study Officials

  • Cyril Chivot, Dr

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2019

First Posted

March 11, 2019

Study Start

February 11, 2019

Primary Completion

August 11, 2020

Study Completion

June 25, 2023

Last Updated

May 10, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations